Tamiflu (Oseltamivir Phosphate) is an antiviral medication used to treat influenza A and influenza B (flu) in children and adults. It works by preventing the spread of flu virus in the body. The drug is available as capsules and oral suspension and should be taken orally within 2 days of start of symptoms to see maximum benefit.
The Global Tamiflu (Oseltamivir Phosphate) Market is estimated to be valued at US$ 464.4 Mn in 2023 and is expected to exhibit a CAGR of 3.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends in the Tamiflu (Oseltamivir Phosphate) Market is the rise in prevalence of influenza diseases. According to WHO, influenza remains a major public health challenge with an estimated 1 billion cases worldwide annually. Influenza activities in North America, Asia and South America are around seasonal levels. In Africa and Europe, influenza activities remain elevated. The continuous emergence of new strains of influenza virus makes antiviral drugs the most effective measure in controlling influenza pandemics. However, the development of antiviral resistance remains a concern. Segment Analysis The global tamiflu market is segmented based on application, distribution channel and geography. By application, the preventive use segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. Preventive use of tamiflu provides protection against influenza virus during a pandemic or an influenza outbreak and reduces disease severity. By distribution channel, the pharmacy stores segment held the largest share of the market in 2022 owing to easy access and availability of tamiflu at most pharmacy stores without prescription. Key Takeaways The Global Tamiflu (Oseltamivir Phosphate) Market Size is expected to witness high growth, exhibiting a CAGR of 3.1% over the forecast period, due to increasing prevalence of influenza globally. Regional analysis - North America dominated the global tamiflu market in 2022 and is expected to continue its dominance over the forecast period. This is attributed to high adoption of preventive medication, presence of developed healthcare infrastructure and strong reimbursement policies in the region. Key players - Key players operating in the tamiflu market are Roche, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Mylan N.V., Apotex Inc., Sandoz AG, Accord Healthcare Ltd. Roche dominated the global tamiflu market in 2022 owing to its well-established brand and broad product portfolio in the influenza treatment segment. For more insights, read - https://www.marketwebjournal.com/tamiflu-oseltamivir-phosphate-market-growth
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |